BRIEF-Mylan announces settlement agreement for generic version of pulmonary disease drug

Oct 9 (Reuters) - Mylan Inc :

* Announces settlement agreement for its first-to-file generic version of

orapred odt�

* Says Mylan will be licensed to sell its prednisolone sodium phosphate odt

product on April 1, 2014

* Says other details of the settlement are confidential

* Says pursuant to the agreement, pending litigation will be dismissed.

* Anticipates that it will be entitled to 180 days of generic market


* Says entered into a settlement agreement with Shionogi Inc. and Cima Labs Inc

* Source text* Further company coverage ((Bangalore Newsroom; +1 646 223 8780))

Related Tags